Kidney Week Humacyte ( (HUMA) ) has shared an announcement. Humacyte, Inc. has initiated a registered direct offering of approximately $30.0 million in common stock and warrants to an ...

On Monday, Humacyte Inc (HUMA) stock saw a decline, ending the day at $4.28 which represents a decrease of $-0.21 or -4.68% from the prior close of $4.49. The stock opened at $4.47 and touched a low ...

NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Humacyte, Inc. (NASDAQ:HUMA) investment and want to learn about a ...

Humacyte Inc’s profitability metrics reveal financial health. The company currently boasts an operating margin of 0.00% with a gross margin of -41.67%. The profit margin, also known as the revenue ...

Under the terms of the securities purchase agreement DURHAM, N.C., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical ... worth of its common stock and warrants in a ...

Humacyte (NASDAQ:HUMA) stock fell 18% in after-hours trading Friday after the company said the FDA has informed the company ...

8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803% Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and ...

Humacyte’s stock has been volatile in 2024. Already up significantly on the year in anticipation of the trauma approval, shares of HUMA peaked (intraday) at $9.97 (up 251% YTD) on May 31 ...

Kathleen Sebelius, a director at Humacyte ($HUMA), sold 1,548 shares of the company on 09-10-2024. We received data on the trade from a recent SEC filing. This was a ...